首頁 > 市場調查報告書 > 醫療設備

手術用器具

市場調查報告書

商品編碼

1439486

Dilator - 全球市場考量、競爭格局、市場預測 (2030)

Dilators - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日期: 按訂單生產 | 出版商:

DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

預計 2024 年至 2030 年預測期內，全球擴張器市場規模將以 8.20% 的複合年增長率成長。市場呈現積極的市場成長，主要得益於胃腸道、老年婦女婦科疾病、鼻腔疾病等各領域手術需求的增加，產品開發的重大進展，以及先進擴張器的快速進步，這些都促進了增長2024 -2030 年預測期內擴張器市場的情況。

擴張器市場動態

擴張器市場的主要驅動因素之一是其在各個外科領域的廣泛使用。對於因食道癌等胃腸道疾病而導致食道狹窄的人，擴張術可以透過擴大食道來緩解症狀。根據美國癌症協會（2022）的數據，預計 2022 年將有 15,530 人（12,410 名男性和 3,120 名女性）死於食道原因。根據世界癌症研究基金會（2018）的數據，2018 年食道癌是男性第 7 位最常見癌症，女性第 13 位最常見癌症。

此外，老年女性子宮頸癌和卵巢癌病例的增加也是推動擴張器市場成長的因素。根據世界衛生組織（WHO）2022年的數據，子宮頸癌是女性第四大常見癌症。

此外，美國癌症協會（2022）的數據顯示，子宮頸癌最常見於35歲至44歲的女性，平均診斷年齡為50歲。超過20%的子宮頸癌病例發生在65歲以上的女性身上。

這些患者需要子宮頸擴張器，以便醫師擴張子宮頸。因此，由於胃腸道和婦科疾病的盛行率不斷增加，擴張器的需求預計將呈現高成長，從而推動擴張器市場在預測期（2024-2030年）的成長，產生正面影響。

除上述因素外，擴張器領域的技術進步，例如改善手術效果的新技術的開發，預計也將有助於擴張器市場的成長。例如，2022 年 5 月，Merit Medical Endotek 宣布推出 Elation5 擴張球囊，這是有史以□□來第一個也是唯一一個五級球囊。 Elation5 旨在在單一球囊導管可用的最寬直徑範圍內逐步擴張胃腸道狹窄。

然而，產品召回和擴張器高成本等某些因素預計將抑制擴張器市場的成長。

此外，由於作為阻止 COVID-19 傳播的必要措施而實施的封鎖規定，擴張器市場經歷了一段時期的暫時衰退。這段時間的主要措施之一是暫停許多擇期手術和門診。這項措施減少了市場對擴張器的需求，因為在封鎖初期，各醫療專科的大量手術被暫停，短時間內限制了市場的成長。話雖如此，由於全球眾多 COVID-19 疫苗的批准和管理，隨著包括醫療保健服務在內的各個領域的活動恢復，擴張器市場預計將在 2024 年進入復甦階段。擴張器市場的未來前景預測期間~2030 年是光明的。

擴張器細分市場分析

就擴張器市場的產品類型細分而言，預計在預測期內（2024-2030年）婦科擴張器將在擴張器市場中佔據較高份額。這是因為婦科擴張器由陰道擴張器、子宮頸擴張器和許多其他產品組成，並用於各種外科手術。

婦科擴張器在外科手術中非常有用，因為它們可以緩慢地打開子宮頸和陰道，幾乎沒有不適。由於最終用戶對早期準確診斷的需求不斷增加，與這些設備相關的專業功能正在促進該產品領域的快速成長。世界各地醫院和診斷中心越來越多地採用婦科擴張器也推動了這一成長。

本報告研究和分析了全球擴張器市場，提供市場規模和預測、驅動因素和挑戰、公司和產品概況等。

擴張器市場驅動因素
- 各領域對手術的需求不斷增加
- 先進擴張器的快速進展
- 產品開發方面的技術進步
擴張器市場的限制與挑戰
- 產品召回
- 擴張器的成本非常高
擴張器市場機遇
- 對先進設備的需求不斷增加
- 推出針對新興市場的產品

第5章擴張器市場的波特五力分析

第6章COVID-19對擴張器市場的影響分析

第7章擴張器市場佈局

依產品類型
- 婦科擴張器
- 尿道擴張器
- 食道擴張器
- 虹膜擴張器
- 其他
依類型
- 機械
- 氣球
依用途
- 診斷
- 治療
按最終用戶
- 醫院、診所
- 醫療保健中心
按地區
- 北美
- 歐洲
- 亞太地區
- 其他領域

第 8 章擴張器市場：全球公司份額分析 - 3 至 5 家主要公司

第 9 章擴張器市場公司與產品概況

Johnson and Johnson (Acclarent, Inc.)
Hebson
CONMED Corporation
Scanlan International
Medtronic
Coloplast (Atos Medical AB)
Teleflex Incorporated
Medpro Medical B.V.
Boston Scientific Corporation
Soul Source Therapeutic Devices, Inc.
Cook
Olympus
GPC Medical Ltd.
Nidhi Meditech Systems
CooperSurgical, Inc.
Hologic, Inc.
MedGyn Products, Inc.
Novo Surgical Inc.
Medicem Group a.s.
Panpac Medical Corp.

第10章KOL觀看次數

第 11 章專案方法

第 12 章關於 DelveInsight

第 13 章免責聲明與聯絡我們

簡介目錄圖表

Product Code: DIMDCL0304

Dilators Market By Product Type (Gynecological Dilators, Urethral Dilators, Esophageal Dilators, Iris Dilators, Others), By Type (Mechanical, Balloon), By Application (Diagnostic, Treatment), By End-User (Hospitals And Clinics, Healthcare Centers, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to rising prevalence of gynecological conditions and rapid evolution of advanced devices

The Global Dilators market is expected to grow at CAGR of 8.20% during the forecast period from 2024 to 2030. The Dilators market is witnessing a positive market growth owing to the growing surgical demand in various fields majorly gastrointestinal, gynecological conditions in geriatric women, nasal conditions, and many others, significant advancement in product development, and rapid evolution of advanced Dilators, thereby contributing to the growth of the Dilators market during the forecast period from 2024-2030.

Dilators Market Dynamics:

One of the main drivers of the Dilators market is their wide application in various surgical fields. For people with esophageal strictures in gastrointestinal conditions like Esophageal cancer, dilation offers relief from symptoms by widening the esophagus. As per the American Cancer Society, 2022, it is estimated that 15,530 deaths (12,410 men and 3,120 women) from Esophageal will occur in 2022. According to the World Cancer Research Fund, 2018, Esophageal cancer is the seventh most commonly occurring cancer in men and the 13th most commonly occurring cancer in women in 2018.

Moreover, the growing cases of cervical & ovarian cancers in geriatric women is another factor responsible for the growth of the Dilators market. As per the data provided by the World Health Organization (WHO) 2022, Cervical cancer is the fourth most common cancer in women.

Moreover, as per the American Cancer Society 2022, Cervical cancers are most frequently diagnosed in women between the ages of 35 and 44 with the average age of diagnosis being 50. More than 20% of cases of cervical cancer are found in women over 65.

These patients require the use of Cervical Dilators to widen the Cervix for the physician. Therefore, the demand for Dilators is set to witness an increased growth owing to the increasing prevalence of growing cases of gastrointestinal and gynecological conditions, thereby positively impacting the dilators market growth during the forecast period (2024-2030).

Along with the factors mentioned above, technological advancements in the field of Dilators such as the development of new techniques to enhance the output of surgeries are also expected to aid in the growth of the Dilators market. For instance, in May 2022, Merit Medical Endotek announced the launch of the Elation5 Dilation Balloon, the first and only 5-stage balloon on the market. Elation5 is designed to incrementally dilate strictures in the gastrointestinal tract with the widest diameter range available on a single balloon catheter.

However, certain factors like product recall and the very high cost of the dilators are expected to restrain the growth of the dilators market.

Moreover, the Dilators market witnessed a period of temporary setback owing to the imposing of the lockdown restrictions as necessary measures to contain the COVID-19 spread. One of the major steps during this was the suspension of numerous elective procedures and outpatient visits which reduced the demand for Dilators in the market as a large number of surgeries across different medical specialties were suspended during the initial lockdown period, thereby limiting the market growth for a short time. Nevertheless, the market for Dilators is in the period of recovery with the resumption of activities across various domains including healthcare services owing to the approval and administration of numerous COVID-19 vaccines across the globe, thereby presenting a positive future outlook for the Dilators market during the forecast period from 2024-2030.

Dilators Market Segment Analysis:

Dilators Market By Product Type (Gynecological Dilators, Urethral Dilators, Esophageal Dilators, Iris Dilators, Others), By Type (Mechanical, Balloon), By Application (Diagnostic, Treatment), By End-User (Hospitals and Clinics, Healthcare Centers, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the Product Type segment of the Dilators market, the Gynecological Dilators are estimated to hold a higher share in the Dilators market during the forecast period (2024-2030). This can be attributed to the fact that Gynecological Dilators are comprised of Vaginal, Cervical Dilators, and many others and are used in different surgical procedures.

The Gynecological Dilators help in opening the cervix and vagina slowly and with little discomfort for surgical purposes. The specific features associated with these devices contribute to the rapid growth of this product segment which attributes to the growing demand for early and accurate diagnostics among end-users. The growing adoption of Gynecological Dilators by hospitals and diagnostic centers around the world is also driving the growth.

Therefore, the growing demand for disease treatment benefits the segment growth of the Dilators market. Hence, their reliability has constantly increased with time and advancements in the newer generation of devices. Therefore, considering the advantages associated with Gynecological Dilators, this category is expected to generate significant revenue share eventually contributing to the overall growth of the global Dilators market in the forecast period.

North America is expected to dominate the overall Dilators Market:

Among all the regions, North America is expected to account for the largest share in the global Dilators market. Factors such as the growing surgical demand in various fields, significant advancement in product development, the rapid evolution of advanced Dilators, increasing government initiatives, and significant product launches are expected to aid in the growth of the North America Dilators Market.

Furthermore, high disposable income, sophisticated healthcare infrastructure, and increased awareness regarding disease progression and new treatments are also expected to aid in the Dilators market growth in this region.

According to the American Cancer Society 2022, about 19,260 new esophageal cancer cases diagnosed (15,310 in men and 3,950 in women) in 2022.

According to the data of the US Department of Health and Human Services 2022, an estimated 293,394 women were living with cervical cancer in the United States in 2018. As per the same statistics, an estimated 235,081 women were living with ovarian cancer in the United States in 2018.

Therefore, the rising prevalence of various surgeries in the country would result in the rising demand for treatments that make use of Dilators, which in turn would provide a conducive growth environment for the North American Dilators market.

Furthermore, the increased emphasis on product development activities and high interest of device manufacturers in accessing local markets further aid in the growth of the regional markets for Dilators.

Therefore, the interplay of various factors such as the presence of a large patient population, encouraging reimbursement policies as well as new product launches in the region is expected to boost the North America Dilators market during the forecast period.

Dilators Market Key Players:

Some of the key market players operating in the Dilators market include Johnson and Johnson (Acclarent, Inc.), Hebson, CONMED Corporation, Scanlan International, Medtronic, Coloplast (Atos Medical AB), Teleflex Incorporated, Medpro Medical B.V., Boston Scientific Corporation, Soul Source Therapeutic Devices, Inc., Cook, Olympus, GPC Medical Ltd., Nidhi Meditech Systems, CooperSurgical, Inc., Hologic, Inc., MedGyn Products, Inc., Novo Surgical Inc., Medicem Group a.s., Panpac Medical Corp. and others.

Recent Developmental Activities in the Dilators Market:

In November 2019, Hologic, Inc. launched the Definity(TM) cervical dilator, a major advancement for gynecological procedures that uses SureAccess(TM) balloon technology to gently and effortlessly access uterine cavities without a tenaculum, lessening patient discomfort and reducing the risk of perforation during dilation.

In May 2019, Baylis Medical announced the US launch and first clinical use of its ExpanSure(TM) Transseptal Dilation System, used in a left-atrial appendage (LAA) closure case performed at the Cleveland Clinic, in Cleveland, Ohio.

Key Takeaways from the Dilators Market Report Study

Market size analysis for current Dilators market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Dilators market.

Top key product/services/Type developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the global Dilators market.

Various opportunities available for the other competitor in the Dilators market space.

What are the top performing segments in 2023? How these segments will perform in 2030.

Which is the top-performing regions and countries in the current Dilators market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Dilators market growth in the coming future?

Target Audience who can be benefited from this Dilators Market Report Study

Dilators products providers

Research organizations and consulting companies

Dilators-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in Dilators

Various End-users who want to know more about the Dilators market and latest technological developments in the Dilators market.

Frequently Asked Questions for Dilators Market:

1. What are Dilators?

A dilator is a surgical device that is used to induce an expansion of a passage or an opening inside the body.

2. What is the market for Global Dilators?

The Global Dilators market is expected to grow at CAGR of 8.20% during the forecast period from 2024 to 2030.

3. What are the drivers for Global Dilators Market?

The Dilators market is witnessing positive market growth owing to growing surgical demand in various fields majorly gastrointestinal, gynecological conditions in geriatric women, nasal conditions, and many others, significant advancement in product development, and rapid evolution of advanced Dilators, thereby contributing to the growth of the Dilators market during the forecast period from 2024-2030.

4. Who are the key players operating in the Global Dilators Market?

5. Which region has the highest share in Dilators Market?

North America is expected to hold the highest share in the revenue in the Dilators market during the forecast period. Factors such as the rising prevalence of gynecological conditions like infections, growing cases of cervical & ovarian cancers in geriatric women, significant advancement in product development, the rapid evolution of advanced Dilators, increasing government initiatives, and significant product launches are expected to aid in the growth of the North America Dilators Market. Furthermore, high disposable income, sophisticated healthcare infrastructure, and increased awareness regarding disease progression and new treatments are also expected to aid in the Dilators market growth in this region.

1.Dilators Market Report Introduction

2.Dilators Market Executive Summary

2.1 Scope of the Study
2.2 Market at Glance
2.3 Competitive Assessment
2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

3.1 The United States
3.2 Europe
3.3 Japan
3.4 China

4. Dilators Market Key Factors Analysis

4.1 Dilators Market Drivers
- 4.1.1 The growing surgical demand in various fields
- 4.1.2 The rapid evolution of advanced Dilators
- 4.1.3 Technological Advancements in Product Development
4.2 Dilators Market Restraints and Challenges
- 4.2.1 Product recalls
- 4.2.2 The very High Cost of the Dilators
4.3 Dilators Market Opportunities
- 4.3.1 Increasing Demand for Advanced Devices
- 4.3.2 Targeting Emerging Markets for Product Launches

5. Dilators Market Porter's Five Forces Analysis

5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Consumers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Dilators Market

7. Dilators Market Layout

7.1 By Product Type
- 7.1.1 Gynecological Dilators
- 7.1.2 Urethral Dilators
- 7.1.3 Esophageal Dilators
- 7.1.4 Iris Dilators
- 7.1.5 Others
7.2 By Type
- 7.2.1 Mechanical
- 7.2.2 Balloon
7.3 By Application
- 7.3.1 Diagnostic
- 7.3.2 Treatment
7.4 By End User
- 7.4.1 Hospitals and Clinics
- 7.4.2 Healthcare Centers
- 7.4.3 Others
7.5 By Geography
- 7.5.1 North America
  - 7.5.1.1 North America Dilators Market, by Product Type
  - 7.5.1.2 North America Dilators Market, by Type
  - 7.5.1.3 North America Dilators Market, by Application
  - 7.5.1.4 North America Dilators Market, by End User
  - 7.5.1.5 North America Dilators Market, by Country
  - 7.5.1.5.1 United States
  - 7.5.1.5.2 Canada
  - 7.5.1.5.3 Mexico
- 7.5.2 Europe
  - 7.5.2.1 Europe Dilators Market, by Product Type
  - 7.5.2.2 Europe Dilators Market, by Type
  - 7.5.2.3 Europe Dilators Market, by Application
  - 7.5.2.4 Europe Dilators Market, by End User
  - 7.5.2.5 Europe Dilators Market, by Country
  - 7.5.2.5.1 France
  - 7.5.2.5.2 Germany
  - 7.5.2.5.3 United Kingdom
  - 7.5.2.5.4 Italy
  - 7.5.2.5.5 Spain
  - 7.5.2.5.6 Russia
  - 7.5.2.5.7 Rest of Europe
- 7.5.3 Asia-Pacific
  - 7.5.3.1 Asia-Pacific Dilators Market, by Product Type
  - 7.5.3.2 Asia-Pacific Dilators Market, by Type
  - 7.5.3.3 Asia-Pacific Dilators Market, by Application
  - 7.5.3.4 Asia-Pacific Dilators Market, by End User
  - 7.5.3.5 Asia-Pacific Dilators Market, by Country
  - 7.5.3.5.1 China
  - 7.5.3.5.2 Japan
  - 7.5.3.5.3 India
  - 7.5.3.5.4 Australia
  - 7.5.3.5.5 South Korea
  - 7.5.3.5.6 Rest of Asia Pacific
- 7.5.4 Rest of the World (RoW)
  - 7.5.4.1 RoW Dilators Market, by Product Type
  - 7.5.4.2 RoW Dilators Market, by Type
  - 7.5.4.3 RoW Dilators Market, by Application
  - 7.5.4.4 RoW Dilators Market, by End User
  - 7.5.4.5 RoW Dilators Market, by Region
  - 7.5.4.5.1 Middle East
  - 7.5.4.5.2 Africa
  - 7.5.4.5.3 South America

8. Dilators Market Global Company Share Analysis - Key 3-5 Companies

9. Dilators Market Company and Product Profiles

9.1 Johnson and Johnson (Acclarent, Inc.)
- 9.1.1. Company Overview
- 9.1.2. Company Snapshot
- 9.1.3. Financial Overview
- 9.1.4 Product Listing
- 9.1.5. Entropy
9.2 Hebson
- 9.2.1. Company Overview
- 9.2.2. Company Snapshot
- 9.2.3. Financial Overview
- 9.2.4 Product Listing
- 9.2.5. Entropy
9.3 CONMED Corporation
- 9.3.1. Company Overview
- 9.3.2. Company Snapshot
- 9.3.3. Financial Overview
- 9.3.4 Product Listing
- 9.3.5. Entropy
9.4 Scanlan International
- 9.4.1. Company Overview
- 9.4.2. Company Snapshot
- 9.4.3. Financial Overview
- 9.4.4 Product Listing
- 9.4.5. Entropy
9.5 Medtronic
- 9.5.1. Company Overview
- 9.5.2. Company Snapshot
- 9.5.3. Financial Overview
- 9.5.4 Product Listing
- 9.5.5. Entropy
9.6 Coloplast (Atos Medical AB)
- 9.6.1. Company Overview
- 9.6.2. Company Snapshot
- 9.6.3. Financial Overview
- 9.6.4 Product Listing
- 9.6.5. Entropy
9.7 Teleflex Incorporated
- 9.7.1. Company Overview
- 9.7.2. Company Snapshot
- 9.7.3. Financial Overview
- 9.7.4 Product Listing
- 9.7.5. Entropy
9.8 Medpro Medical B.V.
- 9.8.1. Company Overview
- 9.8.2. Company Snapshot
- 9.8.3. Financial Overview
- 9.8.4 Product Listing
- 9.8.5. Entropy
9.9 Boston Scientific Corporation
- 9.9.1. Company Overview
- 9.9.2. Company Snapshot
- 9.9.3. Financial Overview
- 9.9.4 Product Listing
- 9.9.5. Entropy
9.10 Soul Source Therapeutic Devices, Inc.
- 9.10.1. Company Overview
- 9.10.2. Company Snapshot
- 9.10.3. Financial Overview
- 9.10.4 Product Listing
- 9.10.5. Entropy
9.11 Cook
- 9.11.1. Company Overview
- 9.11.2. Company Snapshot
- 9.11.3. Financial Overview
- 9.11.4 Product Listing
- 9.11.5. Entropy
9.12 Olympus
- 9.12.1. Company Overview
- 9.12.2. Company Snapshot
- 9.12.3. Financial Overview
- 9.12.4 Product Listing
- 9.12.5. Entropy
9.13 GPC Medical Ltd.
- 9.13.1. Company Overview
- 9.13.2. Company Snapshot
- 9.13.3. Financial Overview
- 9.13.4 Product Listing
- 9.13.5. Entropy
9.14 Nidhi Meditech Systems
- 9.14.1. Company Overview
- 9.14.2. Company Snapshot
- 9.14.3. Financial Overview
- 9.14.4 Product Listing
- 9.14.5. Entropy
9.15 CooperSurgical, Inc.
- 9.15.1. Company Overview
- 9.15.2. Company Snapshot
- 9.15.3. Financial Overview
- 9.15.4 Product Listing
9.16 Hologic, Inc.
- 9.16.1. Company Overview
- 9.16.2. Company Snapshot
- 9.16.3. Financial Overview
- 9.16.4 Product Listing
- 9.16.5. Entropy
9.17 MedGyn Products, Inc.
- 9.17.1. Company Overview
- 9.17.2. Company Snapshot
- 9.17.3. Financial Overview
- 9.17.4 Product Listing
- 9.17.5. Entropy
9.18 Novo Surgical Inc.
- 9.18.1. Company Overview
- 9.18.2. Company Snapshot
- 9.18.3. Financial Overview
- 9.18.4 Product Listing
- 9.18.5. Entropy
9.19 Medicem Group a.s.
- 9.19.1. Company Overview
- 9.19.2. Company Snapshot
- 9.19.3. Financial Overview
- 9.19.4 Product Listing
- 9.19.5. Entropy
9.20 Panpac Medical Corp.
- 9.20.1. Company Overview
- 9.20.2. Company Snapshot
- 9.20.3. Financial Overview
- 9.20.4 Product Listing
- 9.20.5. Entropy